Breast cancer & Mirena IUD: What’s The Link?


i 3 Table of Contents

The Mirena IUD, a widely used intrauterine device, has been the subject of discussion regarding its potential link to breast cancer. This device, which releases the synthetic hormone levonorgestrel, is employed for both contraceptive and therapeutic purposes. While some studies have suggested a possible association with breast cancer, the evidence is not definitive, and more research is needed to establish a clear connection.

Breast cancer awareness poster.

Progesterone and Breast Cancer Risk

Progesterone, a hormone that Mirena mimics through levonorgestrel, is known to play a role in breast cancer development. Given that many breast cancers are sensitive to hormones, there is concern that Mirena could potentially elevate the risk of developing breast cancer. However, this hypothesis remains under investigation, and healthcare providers continue to evaluate the benefits and risks of prescribing Mirena.

How Mirena Works

The Mirena IUD operates by thickening the cervical mucus, creating a barrier that impedes sperm from reaching the eggs released by the ovaries. Additionally, it thins the lining of the uterus, which may reduce ovulation in some users. These effects make Mirena an effective tool for managing heavy menstrual bleeding and other hormone-related health issues.

Research Findings: A Mixed Picture

The U.S. Food and Drug Administration (FDA) has acknowledged the potential breast cancer risk associated with Mirena, particularly for women with a current or past diagnosis of hormone-sensitive breast cancer. However, the FDA also notes that observational studies have not conclusively proven an increased risk.

Studies with No Established Link

Over its more than 15 years on the market, research has yet to provide a conclusive answer about Mirena’s link to breast cancer. Early studies, including one published in Obstetrics & Gynecology in 2005, found no association between Mirena use and an increased risk of breast cancer. A subsequent 2011 study in the journal Contraception supported these findings.

Studies Indicating a Potential Link

Conversely, a 2014 study from Finland reported a higher incidence of breast cancer than expected among Mirena users. Acta Oncologica published a large study in 2015 that also suggested an increased risk. However, a 2016 systematic review in Breast Cancer Research and Treatment did not find a link between progestin-only birth control and a higher incidence of breast cancer, though it called for further research due to the small sample sizes of the studies reviewed.

Breast Cancer and Other IUDs

Research has not indicated an increased risk of breast cancer with the use of non-hormonal IUDs, such as the ParaGard IUD (copper IUD). Women concerned about hormonal birth control may consider ParaGard as an alternative. Additionally, some studies have reported an increase in breast cancer incidence with the use of hormonal oral contraceptives.

Making Informed Choices

While the research is inconclusive, it suggests that the Mirena IUD is unlikely to significantly increase breast cancer risk for most women. Birth control is a personal choice, and its effectiveness and suitability for an individual’s lifestyle are paramount considerations. Women should consult with their healthcare providers to discuss any health concerns and determine the most appropriate birth control method.

Medical Necessity and Alternatives to Mirena

For women experiencing heavy menstrual bleeding, Mirena has been found to be more effective than oral medications. While the nonhormonal copper IUD is not typically recommended for this condition, other more invasive options, such as surgery, are available. It is essential to discuss the most suitable treatment for heavy menstrual bleeding with a healthcare provider, especially for those with a high risk of breast cancer.

In conclusion, the relationship between the Mirena IUD and breast cancer remains an area of active research. Women should engage in open dialogue with their doctors to weigh the benefits and risks of using Mirena or any other form of hormonal contraception.